Associations among Darbepoetin-α, CD34+ Cells and Cardiovascular Disease Events in Patients on Hemodialysis

Associations among Darbepoetin-α, CD34+ Cells and Cardiovascular Disease Events in Patients on Hemodialysis

Background and Objectives: Erythropoiesis-stimulating agents (ESAs) might moderate circulating CD34-positive hematopoietic stem (CD34+) cells. We assessed associations between ESA therapy and CD34+ cells and their impact on cardiovascular disease (CVD) events in patients on prevalent hemodialysis (H...

Full description

Bibliographic Details
Main Authors: Daisuke Sanada, Hirokazu Honda, Noriyuki Kato, Akio Yokochi, Tetsuo Michihata, Tadao Akizawa
Format: Article
Language:English
Published: Karger Publishers 2012-09-01
Series:Nephron Extra
Subjects:
Erythropoiesis-stimulating agent
Cardiovascular disease
Hematopoietic stem cells
Online Access:http://www.karger.com/Article/FullText/341855

Internet

http://www.karger.com/Article/FullText/341855

Similar Items